Cytokinetics: Friday's Worst Performers
This is a news story, published by Yahoo Finance, that relates primarily to CYTK news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
more corporate earnings results. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest stocks news, investor sentiment news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
dismal earnings performanceInsider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey
•Health
Health
In this article, we take a look at where Cytokinetics, Inc. (Nasdaq:CYTK) stands against other Friday’s worst performers

72% Informative
Cytokinetics, Inc. (NASDAQ:CYTK) fell by 12.98 percent on Friday to finish at $ 37.35 apiece.
Overall, CYTK ranks 3rd on our list of Friday ’s worst performers.
While we acknowledge the potential of CYKK as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame.
VR Score
72
Informative language
77
Neutral language
37
Article tone
semi-formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links